GO:0034688 integrin alphaM-beta2 complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034688 (integrin alphaM-beta2 complex) is a heterodimeric integrin composed of one alphaM (ITGAM/CD11b) subunit and one beta2 (ITGB2/CD18) subunit.
• The complex, also known as CD11b/CD18 or CR3, mediates leukocyte adhesion, phagocytosis, and immune signaling.
• Its alphaM subunit contains a beta-propeller domain whose structure depends on association with the beta2 subunit.
• The complex recognizes multiple ligands including fibrinogen gamma-chain and iC3b, and its avidity is dynamically regulated by inside-out signaling.
• Arp2/3 complex is required for macrophage integrin functions but dispensable for FcR phagocytosis, highlighting specific downstream pathways.
• Dysregulation of ITGAM and ITGB2 is implicated in autoimmune and inflammatory diseases, and bioinformatics studies link these genes to polycystic ovary syndrome and type 2 diabetes.
Description
The integrin alphaM-beta2 complex (GO:0034688) is a heterodimeric cell surface receptor that plays a central role in innate immunity and inflammation. It is composed of a non-covalently associated alphaM subunit (ITGAM, CD11b) and a beta2 subunit (ITGB2, CD18), and is also known as complement receptor 3 (CR3) or CD11b/CD18. This complex is predominantly expressed on myeloid cells such as neutrophils, macrophages, and natural killer cells, where it mediates adhesion, migration, phagocytosis, and cellular activation. Researchers study this complex to understand leukocyte biology, host defense, and the pathogenesis of inflammatory and autoimmune diseases. The QuickGO definition states that GO:0034688 is an integrin complex that comprises one alphaM subunit and one beta2 subunit. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of the complex's components, assembly, functions, and methods for experimental interrogation.
integrin alphaM-beta2 complex At A Glance
| GO ID | GO:0034688 |
|---|---|
| GO term | integrin alphaM-beta2 complex |
| Ontology | cellular_component |
| Synonym | alphaM-beta2 integrin complex; Itgam-Itgb2 complex |
| Definition | An integrin complex that comprises one alphaM subunit and one beta2 subunit. |
| Major function | Leukocyte adhesion, phagocytosis, and immune signaling |
| Subunits | AlphaM (ITGAM/CD11b) and beta2 (ITGB2/CD18) |
| Common ligands | iC3b, fibrinogen gamma-chain, ICAM-1 |
| Expression | Myeloid cells: neutrophils, macrophages, dendritic cells, NK cells |
What Is GO:0034688?
GO:0034688, the integrin alphaM-beta2 complex, is a plasma membrane-localized heterodimeric integrin receptor consisting of one alphaM subunit (also called ITGAM or CD11b) and one beta2 subunit (also called ITGB2 or CD18). The two subunits are non-covalently linked, and the alphaM subunit requires association with beta2 for proper folding and surface expression. This complex functions as a receptor for multiple ligands, including complement fragment iC3b, fibrinogen, and intercellular adhesion molecules, and it transduces signals that regulate leukocyte adhesion, phagocytosis, and inflammatory responses.
Why Is integrin alphaM-beta2 complex Important in Cell Biology?
The integrin alphaM-beta2 complex is a critical mediator of innate immune responses, enabling leukocytes to adhere to endothelium, migrate to sites of infection, and engulf complement-opsonized pathogens. Its ability to integrate extracellular signals into cellular responses makes it a key regulator of inflammation and host defense. Dysregulation of this complex contributes to autoimmune diseases, chronic inflammatory conditions, and impaired pathogen clearance. Understanding its structure, activation mechanisms, and downstream signaling is essential for developing targeted therapies and for interpreting genetic variants in ITGAM and ITGB2 that are associated with human disease.
• Mediates phagocytosis of complement-opsonized pathogens via CR3 activity.
• Regulates leukocyte adhesion and migration through avidity modulation.
• Acts as a signaling receptor that activates downstream pathways including Arp2/3-dependent cytoskeletal remodeling.
• Recognizes fibrinogen gamma-chain, linking hemostasis and inflammation.
• Its I domain is a target for cross-reactive antibodies and therapeutic modulation.
• Genetic variants in ITGAM are associated with autoimmune diseases such as systemic lupus erythematosus.
• Beta2 integrin intracellular multi-protein complexes provide structural insights into signaling.
• Plays a role in immune-inflammatory gene networks relevant to polycystic ovary syndrome and type 2 diabetes.
• Serves as a model for studying integrin inside-out signaling and conformational regulation.
• Potential target for anti-inflammatory drug development.
What Happens During integrin alphaM-beta2 complex?
Biosynthesis and subunit assembly
In simple terms: The two protein subunits are made separately and then join together inside the cell.
The alphaM subunit (ITGAM) and beta2 subunit (ITGB2) are synthesized in the endoplasmic reticulum and associate co-translationally or shortly after synthesis. Proper folding of the alphaM beta-propeller domain depends on this association, as the alphaM subunit alone is unstable. The heterodimer then traffics through the Golgi to the plasma membrane, where it functions as a receptor.
Ligand recognition and binding
In simple terms: Once on the cell surface, the complex grabs specific molecules on other cells or pathogens.
The alphaM-beta2 complex binds multiple ligands, including the gamma-chain of fibrinogen, iC3b, and ICAM-1. A novel recognition sequence within the fibrinogen gamma-chain has been identified for this integrin. The I domain of the alphaM subunit contains the major ligand-binding site, and its conformation is regulated by activation signals.
Inside-out signaling and avidity regulation
In simple terms: Signals from inside the cell change the shape of the integrin so it can grab ligands more tightly.
Two signaling mechanisms activate alphaM-beta2 avidity in polymorphonuclear neutrophils: one involving protein kinase C and another involving phosphatidylinositol 3-kinase. These pathways induce conformational changes that shift the integrin from a low-affinity to a high-affinity state, enabling firm adhesion and phagocytosis. The beta2 integrin intracellular multi-protein complexes are critical for transmitting these signals.
Downstream signaling and cytoskeletal remodeling
In simple terms: After binding, the integrin sends signals that reorganize the cell's skeleton to enable movement and engulfment.
Ligand binding triggers intracellular signaling cascades that activate the Arp2/3 complex, which is required for macrophage integrin functions such as spreading and phagocytosis. Interestingly, Arp2/3 is dispensable for FcR-mediated phagocytosis and in vivo motility, indicating specificity in integrin-dependent pathways. These signals also promote the production of reactive oxygen species and cytokine release.
Phagocytosis and pathogen clearance
In simple terms: The complex helps immune cells swallow and destroy pathogens coated with complement proteins.
CR3 (alphaM-beta2; CD11b/CD18) restores IgG-dependent phagocytosis in transfectants expressing a phagocytosis-defective Fc gammaRIIA tail-minus mutant, demonstrating its role in phagocytic signaling. This function is essential for clearing complement-opsonized bacteria and fungi.
Key Genes Involved in GO:0034688 integrin alphaM-beta2 complex
The following genes and proteins are central to the structure, regulation, and function of the integrin alphaM-beta2 complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ITGAM | Encodes alphaM subunit (CD11b) | Required for complex formation and ligand binding |
| ITGB2 | Encodes beta2 subunit (CD18) | Essential for alphaM stability and surface expression |
| FGA/FGB/FGG | Fibrinogen subunits | Provide gamma-chain ligand for alphaM-beta2 |
| ICAM1 | Intercellular adhesion molecule 1 | Ligand for alphaM-beta2 in leukocyte adhesion |
| C3 | Complement component 3 | Generates iC3b ligand for CR3 |
| FCGR2A | Fc gamma receptor IIA | Cooperates with alphaM-beta2 in phagocytosis |
| ARPC2 | Arp2/3 complex subunit | Required for integrin-mediated macrophage functions |
| ARPC3 | Arp2/3 complex subunit | Required for integrin-mediated macrophage functions |
| PRKCA | Protein kinase C alpha | Mediates one pathway of avidity activation |
| PIK3CD | PI3-kinase catalytic subunit | Mediates second pathway of avidity activation |
| ITGAL | Integrin alphaL (CD11a) | Forms alternative beta2 integrin heterodimers |
| ITGB1 | Integrin beta1 | Can associate with alphaM in some contexts |
| SYK | Spleen tyrosine kinase | Downstream signaling from integrins |
| TALIN1 | Talin-1 | Links integrins to actin cytoskeleton |
| KIND1 | Kindlin-1 | Regulates integrin activation |
| RAP1A | Rap1A GTPase | Regulates inside-out integrin signaling |
| VCL | Vinculin | Cytoskeletal adaptor in integrin adhesions |
How Is integrin alphaM-beta2 complex Regulated?
The activity of the integrin alphaM-beta2 complex is regulated primarily through inside-out signaling, where intracellular signals trigger conformational changes that increase ligand-binding affinity. Two distinct signaling mechanisms have been described in neutrophils: one dependent on protein kinase C and another on phosphatidylinositol 3-kinase. Additionally, the beta2 integrin intracellular multi-protein complexes, including talin, kindlin, and Rap1, are critical for transmitting activation signals to the integrin ectodomain. The Arp2/3 complex also modulates downstream integrin functions such as adhesion and phagocytosis.
integrin alphaM-beta2 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ITGAM | Systemic lupus erythematosus, autoimmune inflammation | Knockout mouse or human iPSC-derived macrophages |
| ITGB2 | Leukocyte adhesion deficiency type 1 | Patient-derived iPSCs or knock-in mouse |
| C3 | Complement deficiency, recurrent infections | C3 knockout mouse |
| FCGR2A | Phagocytosis defects, autoimmune susceptibility | Fcgr2a tail-minus mutant transfectants |
| ARPC2/ARPC3 | Macrophage integrin dysfunction | Conditional knockout in macrophages |
Inflammatory and autoimmune diseases
Dysregulation of the integrin alphaM-beta2 complex contributes to chronic inflammation and autoimmunity. Genetic variants in ITGAM are associated with systemic lupus erythematosus and other autoimmune conditions. The complex's role in leukocyte adhesion and activation makes it a key mediator of tissue damage in inflammatory diseases.
Metabolic and endocrine disorders
Bioinformatics and experimental validation studies have identified shared immune-inflammatory gene networks involving ITGAM and ITGB2 in polycystic ovary syndrome and type 2 diabetes mellitus. These findings suggest that the alphaM-beta2 complex may link immune dysfunction to metabolic dysregulation.
Infectious disease and phagocyte defects
Defects in the alphaM-beta2 complex impair phagocytosis of complement-opsonized pathogens, leading to increased susceptibility to bacterial and fungal infections. The complex is essential for CR3-mediated phagocytosis, and its absence or dysfunction results in impaired host defense.
From integrin alphaM-beta2 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ITGAM loss impair phagocytosis? | ITGAM knockout macrophage cell line |
| How does a point mutation in ITGB2 affect ligand binding? | ITGB2 point-mutation knock-in via CRISPR |
| Can tagged alphaM track complex trafficking? | ITGAM knock-in with fluorescent tag |
| Does overexpression of alphaM-beta2 enhance adhesion? | ITGAM/ITGB2 overexpression in myeloid cells |
| What genes regulate alphaM-beta2 avidity? | CRISPR library screening in neutrophils |
| How does Arp2/3 loss affect integrin function? | ARPC2/ARPC3 knockout macrophages |
How to Study the integrin alphaM-beta2 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Surface expression of CD11b/CD18 | Leukocyte phenotyping |
| Static adhesion assay | Integrin-dependent cell binding | Avidity regulation studies |
| Phagocytosis assay | Uptake of opsonized particles | CR3 function assessment |
| Immunoprecipitation-MS | Protein-protein interactions | Beta2 integrin complex composition |
| CRISPR knockout screen | Gene essentiality for integrin function | Identification of Arp2/3 requirement |
| RNA-seq | Transcriptional profiles | Disease network analysis |
| Bioinformatics | Gene network and pathway enrichment | PCOS and T2D studies |
| Live-cell imaging | Cytoskeletal dynamics | Integrin-mediated spreading |
Flow cytometry and adhesion assays
Flow cytometry can measure surface expression of CD11b/CD18, while static and flow adhesion assays quantify leukocyte binding to ICAM-1 or fibrinogen. These methods are used to assess avidity changes following activation.
Phagocytosis assays
Phagocytosis of complement-opsonized particles or IgG-coated targets can be measured using fluorescent microscopy or flow cytometry. These assays distinguish between CR3-mediated and FcR-mediated uptake.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify proteins associated with the beta2 integrin intracellular multi-protein complexes. This approach reveals signaling partners and regulatory networks.
CRISPR screening and bioinformatics
Genome-wide CRISPR knockout screens can identify genes required for integrin alphaM-beta2 function, such as Arp2/3 subunits. Bioinformatics analyses of transcriptomic datasets link ITGAM/ITGB2 to disease networks.
How CRISPR Can Be Used to Study GO:0034688 integrin alphaM-beta2 complex
Knockout
CRISPR knockout of ITGAM or ITGB2 can abolish alphaM-beta2 complex formation and surface expression, enabling loss-of-function studies in macrophages and neutrophils. Knockout of ARPC2 or ARPC3 has been used to demonstrate the requirement for Arp2/3 in integrin-mediated functions.
Point Mutation
Point mutations in the ligand-binding I domain of ITGAM can be introduced to dissect specificity for fibrinogen versus iC3b. Such models help map the recognition sequence and conformational changes required for activation.
Knock-in
Knock-in of fluorescent or epitope tags into ITGAM or ITGB2 allows real-time tracking of complex trafficking and surface dynamics. Tagged knock-in models are valuable for imaging studies in primary immune cells.
Overexpression
Overexpression of ITGAM and ITGB2 in heterologous cells can reconstitute a functional alphaM-beta2 complex and restore phagocytosis in defective cells. This approach is useful for structure-function studies and for testing therapeutic antibodies.
How EDITGENE Supports integrin alphaM-beta2 complex Research
Researchers studying integrin alphaM-beta2 complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, ligand binding, or downstream signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery, from knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for integrin alphaM-beta2 complex research.
Frequently Asked Questions About integrin alphaM-beta2 complex
What is the integrin alphaM-beta2 complex?
The integrin alphaM-beta2 complex (GO:0034688) is a heterodimeric cell surface receptor composed of an alphaM subunit (ITGAM/CD11b) and a beta2 subunit (ITGB2/CD18) that mediates leukocyte adhesion and phagocytosis.
What genes are involved in the integrin alphaM-beta2 complex?
The core genes are ITGAM and ITGB2, which encode the alphaM and beta2 subunits, respectively. Other associated genes include ARPC2, ARPC3, and signaling molecules like PRKCA and PIK3CD.
What is the function of GO:0034688?
GO:0034688 functions as a receptor for complement fragment iC3b, fibrinogen, and ICAM-1, enabling phagocytosis, adhesion, and immune signaling.
How is the integrin alphaM-beta2 complex activated?
It is activated by inside-out signaling through protein kinase C and phosphatidylinositol 3-kinase pathways, which induce conformational changes that increase ligand-binding affinity.
What diseases are associated with integrin alphaM-beta2 complex dysfunction?
Dysfunction is linked to autoimmune diseases like systemic lupus erythematosus, inflammatory conditions, and metabolic disorders such as polycystic ovary syndrome and type 2 diabetes.
What is the role of Arp2/3 in integrin alphaM-beta2 function?
Arp2/3 complex is required for macrophage integrin functions such as spreading and phagocytosis, but is dispensable for FcR-mediated phagocytosis.
How can I study the integrin alphaM-beta2 complex using CRISPR?
CRISPR knockout of ITGAM or ITGB2, point mutations in the I domain, and knock-in of tags are common approaches to dissect its function.
What ligands bind to the integrin alphaM-beta2 complex?
Key ligands include the gamma-chain of fibrinogen, iC3b, and ICAM-1.
What is the synonym for GO:0034688?
Synonyms include alphaM-beta2 integrin complex and Itgam-Itgb2 complex.
What cell types express the integrin alphaM-beta2 complex?
It is predominantly expressed on myeloid cells, including neutrophils, macrophages, dendritic cells, and natural killer cells.
Conclusion
The integrin alphaM-beta2 complex (GO:0034688) is a central mediator of innate immunity, orchestrating leukocyte adhesion, phagocytosis, and inflammatory signaling through its heterodimeric structure and dynamic regulation. Its involvement in autoimmune and metabolic diseases underscores its importance as a research target. Advances in CRISPR-based models and bioinformatics continue to unravel the molecular details of this complex, offering new opportunities for therapeutic intervention.
References
- 1. Ugarova TP et al.. 1998. Identification of a novel recognition sequence for integrin alphaM beta2 within the gamma-chain of fibrinogen.. J Biol Chem 273(35):22519-27 PMID: 9712878
- 2. Plescia J et al.. 1998. Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence.. J Biol Chem 273(32):20372-7 PMID: 9685389
- 3. Bhattacharjya S. 2022. The structural basis of β2 integrin intra-cellular multi-protein complexes.. Biophys Rev 14(5):1183-1195 PMID: 36345283
- 4. Jones SL et al.. 1998. Two signaling mechanisms for activation of alphaM beta2 avidity in polymorphonuclear neutrophils.. J Biol Chem 273(17):10556-66 PMID: 9553116
- 5. Lu C et al.. 1998. The structure of the beta-propeller domain and C-terminal region of the integrin alphaM subunit. Dependence on beta subunit association and prediction of domains.. J Biol Chem 273(24):15138-47 PMID: 9614126
- 6. Worth RG et al.. 1996. CR3 (alphaM beta2; CD11b/CD18) restores IgG-dependent phagocytosis in transfectants expressing a phagocytosis-defective Fc gammaRIIA (CD32) tail-minus mutant.. J Immunol 157(12):5660-5 PMID: 8955219
- 7. Rotty JD et al.. 2017. Arp2/3 Complex Is Required for Macrophage Integrin Functions but Is Dispensable for FcR Phagocytosis and In Vivo Motility.. Dev Cell 42(5):498-513.e6 PMID: 28867487
- 8. Liu X et al.. 2026. Shared immune-inflammatory gene networks and drug prediction in polycystic ovary syndrome and type 2 diabetes mellitus: a bioinformatics and experimental validation study.. Front Endocrinol (Lausanne) 17:1747045 PMID: 42109727
